Cannabis Onset and Duration Technologies: Patent Filing Trends (Jan 2009- Jun 2019)

The improvement in pharmacokinetics would eventually result in an enhanced onset and duration time. The onset and duration depend on multiple factors ranging from the drug composition to the route of administration. But in the case of cannabinoid, it’s a big obstacle because of its lipophilic nature. It only shows 20-25% bioavailability even in the most optimistic scenario.

Onset time can be managed to some extent by controlling the dosage that is, by modifying the drug composition and their properties. Some other ways to increase onset and duration are by:

  • Adding excipients
  • Developing unique systems
  • Improving dosage form
  • Improving Route form

Researchers are finding ways to manage onset and duration as to increase the effectiveness. There are 195 Patent families filed globally under the onset and duration technology node of cannabis.

Below infographics depicts how patent filing trend evolved over the years in Onset and Duration Technologies:

Explore Other Patent Statistics on Cannabis Industry

Related Articles

PerkinElmer Patents – Key Insights and Stats

PerkinElmer has a total of 6440 patents globally, out of which 3508 have been granted. Of these 6440 patents, more than 49% patents are active. United States of America is where PerkinElmer has filed the maximum number of patents, followed by Europe and China. Parallelly, United States of America seems

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.